Hempvana Ultra Strength Pain Relief Cream - Deep Freeze

Manufacturer
Telebrands Corp | Neutraderm, Inc.
Effective date
2021-10-29
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
legacy-cache
Hydrated at
2026-08-01 22:30:14

Label at a glance#

ProductHempvana Ultra Strength Pain Relief Cream - Deep Freeze
Active ingredientMENTHOL
Label structure8 sections

Indications and uses

temporarily relieves minor pain associated with: arthritis simple backache muscle strains sprains bruises

Dosage and administration

Adults and children 2 years of age and older: Apply to affected area not more than 3 to 4 times daily. Children under 2 years of age: consult a physician.

Label contents#

Full prescribing information#

Active Ingredient

OTC - ACTIVE INGREDIENT SECTION

Menthol 10%

Purpose

OTC - PURPOSE SECTION

Menthol 10%...................Topical Analgesic

Uses

INDICATIONS & USAGE SECTION

temporarily relieves minor pain associated with:

  • arthritis
  • simple backache
  • muscle strains
  • sprains
  • bruises

Warnings

WARNINGS SECTION

For external use only

Allergy alert: If prone to allergic reaction from aspirin or salicylates, consult a doctor before use.

OTC - WHEN USING SECTION

When using this product

  • use only as directed. Read and follow all directions and warnings on this label.
  • do not bandage tightly or apply local heat (such as heating pads) to the area of use.
  • avoid contact with eyes or mucous membranes.
  • do not apply to wounds or damaged, broken or irritated skin.
  • do not use at the same time as other topical analgesics.

OTC - STOP USE SECTION

Stop use and ask a doctor if

  • condition worsens
  • symptoms persist for more than 7 days or clear up and occur again wthin a few days
  • redness is present or irritation develops

OTC - PREGNANCY OR BREAST FEEDING SECTION

If pregnant or breast-feeding, ask a health professional before use.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children and pets. If swallowed, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

  • Adults and children 2 years of age and older: Apply to affected area not more than 3 to 4 times daily.
  • Children under 2 years of age: consult a physician.

Inactive ingredients

INACTIVE INGREDIENT SECTION

Water/Aqua/Eau, Caprylic/Capric Triglyceride, Glyceryl Stearate, Glycerin, Dimethicone, Cetearyl Alcohol, Cannabis Sativa (Hemp) Seed Oil, PEG-100 Stearate, Stearic Acid, Potassium Cetyl Phosphate, Ilex Paraguariensis Leaf Extract, Vitis Vinifera (Grape) Seed Oil, Tocopheryl Acetate, Phenoxyethanol, Acrylates/C10-30 Alkyl Acrylate Crosspolymer, Ethylhexylglycerin, Sodium Hydroxide, Disodium EDTA, Blue 1 (CI 42090)

Questions?

OTC - QUESTIONS SECTION

Questions? Call (855) 877-4503 (M-F, 9am-5pm EST)

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Hempvana Brand

Ultra Strength Pain Relief Cream

Deep Freeze

+Hemp Seed Oil

For Moisturization

Menthol 10%

For Pain

Net Wt. 4 OZ (119 g)

11

22

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 21 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
73287-01973287-019-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 20 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
0dabf5de-008f-50dc-e063-6294a90a562bcf848e10-90d9-52fe-e053-2995a90ad3442023-12-29WarningsExact identifier
spl set id: cf848e10-90d9-52fe-e053-2995a90ad344

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.